A number of firms have modified their ratings and price targets on shares of Core Scientific (NASDAQ: CORZ) recently:
- 8/3/2026 – Core Scientific had its price target raised by B. Riley Financial, Inc. from $33.00 to $42.00. They now have a “buy” rating on the stock.
- 7/30/2026 – Core Scientific was given a new $33.00 price target by Capital One Financial Corporation.
- 7/30/2026 – Core Scientific was upgraded by Freedom Capital from “hold” to “strong-buy”.
- 7/30/2026 – Core Scientific was upgraded by Keefe, Bruyette & Woods from “market perform” to “outperform”. They now have a $28.00 price target on the stock, up from $25.00.
- 7/29/2026 – Core Scientific had its “buy” rating reaffirmed by Compass Point. They now have a $36.00 price target on the stock.
- 7/29/2026 – Core Scientific had its price target raised by Needham & Company LLC from $29.00 to $35.00. They now have a “buy” rating on the stock.
- 7/29/2026 – Core Scientific had its “buy” rating reaffirmed by Wolfe Research.
- 7/29/2026 – Core Scientific had its price target raised by Canaccord Genuity Group Inc. from $30.00 to $36.00. They now have a “buy” rating on the stock.
- 7/28/2026 – Core Scientific had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $29.00 price target on the stock.
- 7/28/2026 – Core Scientific had its “buy” rating reaffirmed by BTIG Research. They now have a $38.00 price target on the stock.
- 7/27/2026 – Core Scientific was downgraded by Keefe, Bruyette & Woods from “outperform” to “market perform”. They now have a $25.00 price target on the stock.
- 7/17/2026 – Core Scientific had its “sell (d-)” rating reaffirmed by Weiss Ratings.
- 6/24/2026 – Core Scientific had its price target raised by BTIG Research from $33.00 to $38.00. They now have a “buy” rating on the stock.
Insider Buying and Selling
In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $19.97, for a total value of $199,700.00. Following the transaction, the insider directly owned 1,969,101 shares of the company’s stock, valued at $39,322,946.97. This represents a 0.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold a total of 100,000 shares of company stock valued at $2,448,300 in the last quarter. Insiders own 1.70% of the company’s stock.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
See Also
- Five stocks we like better than Core Scientific
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Core Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.
